|
TaiGen Biotechnology Company,a leading research-based and product-driven biotechnology company in Taiwan, and Zhejiang Medicine Company, (ZMC) have signed an exclusive agreement to manufacture and commercialize nemonoxacin, a novel broad-spectrum antibiotic, in China. Nemonoxacin is a novel broad-spectrum non-fluorinated quinolone antibiotic under development for respiratory infections. TaiGen will be responsible for completing the phase III clinical trial for community acquired pneumonia (CAP) in China. ZMC will be responsible for manufacturing, sales and marketing of nemonoxacin in China through its wholly-owned subsidiary, XinChang Pharmaceuticals. TaiGen will retain full development and commercialization rights outside the licensed territory including Taiwan, the United States, European Union, and Japan. Under the terms of the agreement, TaiGen will receive an upfront payment of US$ 8 million from ZMC and will receive additional milestones as well as royalties on product sales. The term of the agreement is 20 years. Nemonoxacin has demonstrated efficacy and safety in CAP and diabetic foot infection in multinational and multi-centre clinical trials conducted by TaiGen. In particular, nemonoxacin has excellent activity against drug-resistant bacteria such as methicillin resistant Staphylococcus aureus (MRSA) and quinolone-resistant MRSA. Nemonoxacin is taken once-a-day and available in both oral and intravenous formulations. Currently, TaiGen is completing a phase III CAP trial with more than 500 patients from Taiwan and China and expects to file new drug applications in Taiwan and China simultaneously in early 2013. China is one of the major antibiotic markets in the world. According to IMS, the sales of antibiotics in 2011 were approximately US$ 11 billion (RMB 68 billion) and account for almost 20 per cent of the total pharmaceuticals sales. Rate of antibiotic resistant infections in China is among the highest in the world. Li Chun Bo, chairman of the ZMC, commented, “We are impressed with nemonoxacin’s broad spectrum activity towards drug-resistant bacteria, in particular, MRSA, and excellent safety profile. We are excited to establish this partnership with TaiGen because of its reputation as a premier research-based biotech company in Asia. This partnership will break new ground for cross-strait collaboration in the pharmaceutical industry. Nemonoxacin will be a major addition to ZMC’s antibiotic product line and significant profit driver.” Dr Ming-Chu Hsu, president and chief executive officer of TaiGen, said, “China is the world’s fastest growing pharmaceutical market. It is poised to overtake Japan as the second largest pharmaceutical market. We are extremely please to establish our nemonoxacin partnership with ZMC, a first-class pharmaceutical company and major player in the Chinese antibiotics market. With nemonoxacin, TaiGen and ZMC together will bring new medicine to treat unmet medical needs in China. This partnership will not only set a new record for pharmaceutical licensing involving a Taiwanese and a Chinese company but hopefully will also become a model of the future collaborations.” Dr Hsu also added, “With the conclusion of the partnership in China, we will actively pursue nemonoxacin licensing discussions in other territories such as European Union.” ZMC Limited is a leading pharmaceutical company in China specializing in sales and distribution of pharmaceuticals and manufacturing of active pharmaceutical ingredients (vitamins and antibiotics). This site contains materials from other clearly stated media sources for the purpose of discussion stimulation and content enrichment among our members only.
whatsonningbo.com does not necessarily endorse their views or the accuracy of their content. For copyright infringement issues please contacteditor@whatsonningbo.com
The e-commerce company in China offers quality products such as Turbo Compressor Wheels Manufacturer , Compressor housing Manufacturer, and more. For more , please visit Compressor wheels today!
Related Articles -
Turbo Compressor Wheels Manufacturer, Compressor housing Manufacturer,
| 
